InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
T+90 hit rate
20%
T+90 mean return
-8.7%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Virani Shafique, Directeur du Développement Corporatif. Insider active across 1 company, notably Recursion Pharmaceuticals, INC.. In total, 24 filings have been logged. Split: 0 buy · 1 sell. Total volume traded: €199k. Activity tracked since 2 June 2021. The latest transaction was disclosed on 16 January 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations24 total
18,000 shares@ US$2.224.4% of flowClass A Common StockSEC:0001209191-24-001870:0
18,000 shares@ US$2.224.4% of flowClass A Common StockSEC:0001209191-23-059254:0
18,000 shares@ US$2.224.4% of flowClass A Common StockSEC:0001209191-23-055843:0
18,000 shares@ US$2.224.6% of flowClass A Common StockSEC:0001209191-23-053107:0
18,000 shares@ US$2.225.0% of flowClass A Common StockSEC:0001209191-23-050033:0
3,603 shares@ US$9.193.7% of flowClass A Common StockSEC:0001209191-23-046424:0
20,000 shares@ US$2.224.8% of flowClass A Common StockSEC:0001209191-23-043581:0
30,000 shares@ US$2.227.2% of flowClass A Common StockSEC:0001209191-23-042794:0
30,000 shares@ US$2.227.3% of flowClass A Common StockSEC:0001209191-23-038616:0
25,000 shares@ US$8.5824.1% of flowClass A Common StockSEC:0001209191-23-034601:0
2,230 shares@ US$5.601.4% of flowClass A Common StockSEC:0001209191-23-030380:0
7,486 shares@ US$2.221.9% of flowClass A Common StockSEC:0001209191-23-010774:0
106,253 shares0Class A Common StockSEC:0001209191-23-007045:0
5,000 shares@ US$2.221.2% of flowClass A Common StockSEC:0001209191-23-004043:0
5,000 shares@ US$2.221.3% of flowClass A Common StockSEC:0001209191-22-061999:0
613 shares@ US$11.860.9% of flowClass A Common StockSEC:0001209191-22-057708:0
5,000 shares@ US$2.221.4% of flowClass A Common StockSEC:0001209191-22-053981:0
5,000 shares@ US$2.221.3% of flowClass A Common StockSEC:0001209191-22-050400:0
613 shares@ US$12.960.9% of flowClass A Common StockSEC:0001209191-22-046464:0
870 shares@ US$5.670.0002% mcap2.8% of flowClass A Common StockSEC:0001209191-22-030257:0
40,225 shares0Class A Common StockSEC:0001209191-22-007918
40,225 shares0Class A Common StockSEC:0001209191-22-007918:0
45,045 shares@ US$2.220.0038% mcap48.6% of flowClass A Common StockSEC:0001209191-21-038174:0
45,045 shares@ US$2.229.9% of flowClass A Common StockSEC:0001209191-21-038174
24 of 24 declarations
About Virani Shafique
Shafique Virani serves as Chief Corporate Development Officer at Recursion Pharmaceuticals, Inc. In this role, he is responsible for identifying and implementing new growth opportunities for the company. His expertise in strategy and business development is essential to support the innovation and sustainability of the organization.
